Fentanyl can cause hallucinations and psychotic symptoms, though these effects are uncommon relative to its more familiar risks like respiratory depression. The pathways to fentanyl-related psychosis are surprisingly varied: direct neurotoxicity from the drug itself, delirium triggered in hospital settings, brain damage from oxygen deprivation during overdose, withdrawal states, and adulterants mixed into illicit supply all play distinct roles. Sorting out which pathway is actually responsible matters, because the treatment and prognosis differ considerably depending on the cause.
Hallucinations as a Direct Side Effect
Opioid-induced hallucinations are a recognized but relatively rare adverse effect across the opioid drug class. A review of the medical literature found that most documented cases arise in the context of end-of-life care and cancer pain management, where patients are on sustained or escalating opioid doses for long periods.1PubMed Central. Opioid-induced Hallucinations: A Review of the Literature, Pathophysiology, Diagnosis, and Treatment Fentanyl, as one of the more potent opioids in clinical use, is no exception. A published case report describes a 73-year-old woman who arrived at the emergency department with both auditory and visual hallucinations caused by a fentanyl patch. Once the patch was removed and the fentanyl dose adjusted, the hallucinations resolved during follow-up.2PubMed. Neuropsychiatric side effects due to a transdermal fentanyl patch: hallucinations
Cases like that illustrate a pattern: the hallucinations tend to emerge with accumulation of the drug in the body (especially in older adults whose kidneys or liver clear medications more slowly) and typically resolve once the opioid is reduced or switched to a different one. The hallucinations may be visual, auditory, or both, and they can be vivid enough to cause genuine distress and confusion for the patient and their family. However, straightforward fentanyl-induced hallucinations in someone with no other risk factors remain the least common of the pathways discussed here.
Fentanyl and Delirium in Hospital Settings
Where fentanyl’s psychiatric effects show up most clearly in clinical data is not frank psychosis but delirium, a state of acute confusion that can include hallucinations, agitation, disorientation, and disordered thinking. In intensive care units, fentanyl is widely used for pain control and sedation in ventilated patients. A trial comparing fentanyl with morphine for this purpose found that fentanyl was associated with a higher rate of delirium, and that the dose of opioid was linearly related to how often antipsychotic medications had to be given.3Journal of Critical Care. Delirium in ventilated patients receiving fentanyl and morphine for Analgosedation: Findings from the ANALGESIC trial
A separate study looked specifically at patients transferred to the ICU after cardiac surgery. Among more than 5,300 patients, those who received fentanyl had roughly 70 percent higher risk of developing delirium within seven days of surgery compared to the morphine group, and their delirium tended to set in sooner.4PubMed Central. Early Use of Fentanyl Increases Risk of Delirium in Patients Transfer to the intensive Care Unit After Cardiac Surgery Immediately: A Target Trial Emulation These findings matter because ICU delirium is not a minor nuisance. It is associated with longer hospital stays, worse cognitive outcomes, and higher mortality. The fact that fentanyl appears to carry more delirium risk than morphine in these settings has practical implications for how clinicians choose sedation protocols.
It is worth noting that ICU delirium is multifactorial. Sleep deprivation, infection, advanced age, pre-existing cognitive problems, and the critical illness itself all contribute. Fentanyl does not cause delirium in isolation so much as it raises the odds in patients who are already vulnerable. Still, the dose-response relationship, where more fentanyl means more delirium, points to a genuine pharmacological contribution rather than just coincidence.
What Fentanyl Does to the Brain
Fentanyl’s primary action is binding to mu-opioid receptors, the same receptors targeted by morphine, heroin, and other opioids. But fentanyl is unusually potent and fast-acting, which means it hits these receptors harder and more abruptly than most other opioids. Research in animal models has shown that repeated fentanyl exposure triggers lasting changes in how brain circuits handle dopamine. Specifically, chronic fentanyl use rearranges signaling in the striatum, a brain region involved in reward, motivation, and movement, in ways that ultimately suppress dopamine activity.5Cell Reports. Striatal μ-opioid receptor activation triggers direct-pathway GABAergic plasticity and induces negative affect A brain starved of normal dopamine signaling is prone to negative emotional states and, in some circumstances, perceptual disturbances.
Beyond receptor-level changes, fentanyl appears to damage the blood-brain barrier, the protective lining that controls what substances can enter the brain from the bloodstream. In mouse studies, fentanyl reduced the expression of key structural proteins (claudin-5 and ZO-1) in the barrier within the striatum.6PubMed Central. Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice A leakier blood-brain barrier allows inflammatory molecules and other substances to enter the brain more freely, potentially worsening neuroinflammation. This research was done in the context of HIV, where both fentanyl and the virus independently damage the barrier, but the fentanyl effect held regardless of HIV status. While these are animal findings that cannot be directly mapped to human psychosis, they offer a plausible biological explanation for why heavy, chronic fentanyl use could make the brain more vulnerable to psychiatric disturbances over time.
The Adulterant Problem
If you spend time around harm-reduction communities or emergency departments, you have probably heard people describe fentanyl-related hallucinations that sound nothing like typical opioid effects: intensely visual, psychedelic in character, sometimes compared to DMT. There is growing evidence that these experiences are often not caused by fentanyl itself but by substances mixed into the illicit supply.
A recent analysis of drug-checking data found that samples containing medetomidine, a veterinary sedative increasingly found as an adulterant in the street drug supply, were about twelve times more likely to be associated with hallucinations than samples without it.7PubMed Central. Emergence of Medetomidine in the Unregulated Drug Supply and Its Association With Hallucinogenic Effects Users described these hallucinations as “intense,” “trippie like DMT,” “psychedelic,” and “dissociative seeming.” Meanwhile, fentanyl precursors and impurities in the same dataset were actually associated with a lower likelihood of hallucinations, suggesting that fentanyl itself was not the culprit in most of these reports.
This distinction matters enormously. Medetomidine belongs to the same drug family as xylazine (another common fentanyl adulterant) and dexmedetomidine (used in hospital sedation). These alpha-2 adrenergic agonists have very different pharmacology from opioids, and the hallucinations they produce do not respond to naloxone. Someone experiencing medetomidine-induced psychosis after using what they believed was fentanyl will not improve with standard opioid overdose reversal. Emergency providers and people who use drugs both need to understand that the hallucinogenic effects increasingly blamed on fentanyl may actually be coming from what is mixed in with it.
Withdrawal and Precipitated Delirium
Fentanyl withdrawal is notoriously intense, in part because the drug’s potency and short duration of action create steep neurological swings. While typical opioid withdrawal is miserable but not usually dangerous in otherwise healthy adults, severe withdrawal can sometimes cross the line into delirium, a state that includes confusion, agitation, and hallucinations.
A systematic review of withdrawal-induced delirium in opioid dependence described how abruptly cutting off opioid receptor activation, whether through running out of drug or through the use of an opioid-blocking medication like naloxone or naltrexone, can produce sympathetic overdrive, acute neurotransmitter imbalance, and profound cognitive disruption within minutes.8PubMed Central. Withdrawal-Induced Delirium in Opioid Dependence: A Systematic Review This is especially dramatic in what is called precipitated withdrawal, where naloxone or naltrexone is given to someone who still has opioids on their receptors. The opioid is essentially ripped off the receptors all at once, and the brain’s response can be explosive.
With fentanyl specifically, precipitated withdrawal has become more clinically challenging in recent years. Because fentanyl accumulates in body fat and can continue to leach into the bloodstream for days after last use, people may still have significant fentanyl on board even when they feel they have waited long enough to start medication-assisted treatment. When they take a partial agonist like buprenorphine too early, the result can be severe precipitated withdrawal that includes psychotic features. This scenario has become a well-known complication in addiction medicine and has prompted changes to how clinicians initiate buprenorphine in fentanyl-dependent patients.
What Happens to the Brain During Overdose
Perhaps the most consequential pathway from fentanyl to lasting psychiatric symptoms runs through overdose itself. Fentanyl overdose kills by suppressing breathing, and even when the person survives, the period of oxygen deprivation can cause real structural damage to the brain. Research using brain imaging found that people with a history of opioid overdose had lower volume in the hippocampus, a brain region critical for memory and highly sensitive to oxygen deprivation, compared to opioid users who had never overdosed.9PubMed Central. Collateral Damage: Neurological Correlates of Non-Fatal Overdose in the Era of Fentanyl-Xylazine The researchers linked this to a recently recognized amnestic syndrome, where people develop severe memory problems after surviving an overdose.
Hippocampal damage and broader hypoxic brain injury can also contribute to psychiatric symptoms including confusion, personality changes, and in some cases psychotic features. These are not caused by fentanyl’s pharmacology per se but by the oxygen deprivation that fentanyl overdose creates. The distinction is meaningful: someone who develops hallucinations after a near-fatal overdose may have sustained brain injury that will not resolve simply by stopping the drug. This is a growing concern as non-fatal overdoses have become more common in the fentanyl era, since fentanyl’s potency makes accidental overdose more likely than with heroin or prescription opioids.
The Naloxone Wake-Up
A related but distinct phenomenon is what happens in the minutes after someone is revived from an opioid overdose with naloxone. Naloxone strips opioids off the brain’s receptors, which can plunge the person into immediate withdrawal. A qualitative study of 56 overdose reversals observed by people who use opioids found that about 41 percent of events were characterized by what researchers labeled “rage,” involving angry, hostile, and aggressive outbursts by the person who had just been revived.10PubMed Central. Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from a qualitative study Other reversals were described in terms of feeling immediately and severely dopesick, along with various other physiological and psychological effects.
These post-reversal states can look alarming to bystanders and even to medical professionals. The person may be confused, combative, and appear to be experiencing something resembling acute psychosis. This is largely a product of precipitated withdrawal rather than a lasting psychiatric effect, and it typically resolves within the hour as the naloxone wears off (naloxone’s duration of action is shorter than fentanyl’s, which is why repeated doses or monitoring are often necessary). But the experience is distressing enough that some people who use drugs cite fear of naloxone reversal as a reason they might hesitate to call for help during an overdose, which is a significant public health problem.
Fentanyl Use and Pre-Existing Psychiatric Illness
Disentangling fentanyl’s direct psychiatric effects from the mental health conditions that frequently co-exist with opioid use is one of the hardest challenges in this area. A study of emergency department patients who tested positive for illicit fentanyl found that about 36 percent had co-occurring psychiatric disorders. Mood disorders were the most common, present in nearly half of that group, followed by psychotic disorders at about 19 percent and anxiety disorders at roughly 9 percent.11Nature. Co-occurring illicit fentanyl use and psychiatric disorders in emergency department patients More than a fifth of those with psychiatric diagnoses had more than one.
This overlap creates a chicken-and-egg problem. Someone who arrives at the emergency department using fentanyl and experiencing psychotic symptoms may have a pre-existing psychotic disorder worsened by substance use, a substance-induced psychosis triggered by fentanyl or its adulterants, delirium from an overdose or withdrawal, or some combination of all three. A literature review on substance-induced psychosis noted that the tendency to develop psychosis appears to increase with the severity of use and addiction, and that while there are some phenomenological clues to distinguish substance-induced psychosis from a primary psychotic disorder like schizophrenia, the distinction is often difficult to make in the acute setting.12PubMed Central. Substance-Induced Psychoses: An Updated Literature Review
For clinicians, getting this right is more than academic. A patient whose psychosis is driven by fentanyl withdrawal needs a completely different treatment approach than one with underlying schizophrenia. Misdiagnosing substance-induced psychosis as a primary disorder can lead to years of unnecessary antipsychotic medication, while missing a primary disorder behind the substance use can leave someone chronically untreated.
Children and Heightened Vulnerability
Children represent a population where fentanyl’s neuropsychiatric effects deserve special attention. A report on fentanyl-induced neurotoxicity in pediatric palliative care described the condition as uncommon but presenting with a wide and nonspecific range of symptoms including severe pain, allodynia (pain from stimuli that should not be painful), insomnia, agitation, hallucinations, behavioral changes, and headache.13PubMed. Fentanyl-Induced Neurotoxicity in Children The nonspecific nature of these symptoms makes them easy to miss or attribute to the child’s underlying illness rather than to the fentanyl itself.
Children’s brains are still developing, which may make them more susceptible to both the direct neurotoxic effects and the downstream consequences of opioid-induced changes to dopamine signaling and blood-brain barrier integrity. Outside of palliative care, accidental pediatric fentanyl exposures have been rising in parallel with the drug’s spread in the illicit market, and even small exposures can produce profound effects in a child-sized body. While the literature on fentanyl-specific psychosis in children remains thin, the available evidence suggests that clinicians should have a low threshold for considering fentanyl neurotoxicity when a child on opioid therapy develops unexplained neuropsychiatric symptoms.
Why “Fentanyl Psychosis” Is Harder to Study Than You Might Think
One of the frustrations in answering the title question cleanly is that most of the published literature on opioid-induced hallucinations comes from patients on prescription opioids in controlled medical settings, not from people using illicit fentanyl. The two situations are very different. A patient on a fentanyl patch in a hospital is getting a known dose of a known drug, with monitoring. Someone buying powder on the street is getting an unknown dose of fentanyl (or one of its many analogues) potentially contaminated with medetomidine, xylazine, benzodiazepines, or stimulants. The psychiatric effects observed in that second group reflect the combined action of everything in the mixture, not just fentanyl.
This makes it genuinely difficult to separate what fentanyl alone does to the mind from what the broader ecosystem of illicit fentanyl use does. Controlled studies in which volunteers are given pure fentanyl and monitored for psychotic symptoms are not ethically feasible at the doses seen in street use. Animal studies can illuminate mechanisms but cannot fully model the subjective experience of hallucinations or psychosis. And observational studies of people who use illicit fentanyl cannot control for polydrug use, adulterants, sleep deprivation, malnutrition, trauma, and the other compounding factors that are nearly universal in that population.
What the evidence supports, taken as a whole, is that fentanyl can contribute to psychotic symptoms through several distinct mechanisms: direct neurotoxicity at high or sustained doses, delirium in medically vulnerable patients, hypoxic brain injury from overdose, withdrawal states, and neuroinflammatory changes from chronic use. At the same time, the dramatic hallucinations increasingly reported in the context of street fentanyl use appear to be driven at least partly by adulterants like medetomidine rather than by fentanyl itself. For anyone trying to understand or treat these symptoms, identifying which pathway is at work is not optional. It changes everything about the prognosis and the response.